nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—CYP2E1—liver cancer	0.254	0.503	CbGaD
Quinine—CYP1A1—liver cancer	0.25	0.497	CbGaD
Quinine—CYP3A7—Sorafenib—liver cancer	0.0405	0.14	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0405	0.14	CbGbCtD
Quinine—CYP3A5—Sorafenib—liver cancer	0.0304	0.105	CbGbCtD
Quinine—CYP2C8—Sorafenib—liver cancer	0.0292	0.101	CbGbCtD
Quinine—CYP2C19—Sorafenib—liver cancer	0.0245	0.0848	CbGbCtD
Quinine—CYP1A2—Sorafenib—liver cancer	0.0226	0.0783	CbGbCtD
Quinine—CYP2C9—Sorafenib—liver cancer	0.0204	0.0705	CbGbCtD
Quinine—ABCB1—Sorafenib—liver cancer	0.0198	0.0685	CbGbCtD
Quinine—CYP2D6—Sorafenib—liver cancer	0.0186	0.0645	CbGbCtD
Quinine—ABCB1—Doxorubicin—liver cancer	0.012	0.0415	CbGbCtD
Quinine—CYP3A4—Sorafenib—liver cancer	0.0118	0.041	CbGbCtD
Quinine—CYP2D6—Doxorubicin—liver cancer	0.0113	0.0391	CbGbCtD
Quinine—CYP3A4—Doxorubicin—liver cancer	0.00718	0.0249	CbGbCtD
Quinine—Quinidine—CYP2E1—liver cancer	0.00117	0.503	CrCbGaD
Quinine—Quinidine—CYP1A1—liver cancer	0.00115	0.497	CrCbGaD
Quinine—Neutropenia—Sorafenib—liver cancer	0.000697	0.00688	CcSEcCtD
Quinine—Optic neuritis—Doxorubicin—liver cancer	0.000661	0.00652	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.000659	0.00651	CcSEcCtD
Quinine—Renal failure—Sorafenib—liver cancer	0.000654	0.00645	CcSEcCtD
Quinine—Jaundice—Sorafenib—liver cancer	0.000648	0.0064	CcSEcCtD
Quinine—Myasthenia—Doxorubicin—liver cancer	0.000647	0.00638	CcSEcCtD
Quinine—Haemoglobin—Sorafenib—liver cancer	0.0006	0.00592	CcSEcCtD
Quinine—Haemorrhage—Sorafenib—liver cancer	0.000597	0.00589	CcSEcCtD
Quinine—Urinary tract disorder—Sorafenib—liver cancer	0.000589	0.00582	CcSEcCtD
Quinine—Urethral disorder—Sorafenib—liver cancer	0.000585	0.00577	CcSEcCtD
Quinine—Scotoma—Epirubicin—liver cancer	0.000578	0.00571	CcSEcCtD
Quinine—Erythema multiforme—Sorafenib—liver cancer	0.000564	0.00557	CcSEcCtD
Quinine—Necrosis—Epirubicin—liver cancer	0.00056	0.00552	CcSEcCtD
Quinine—Tinnitus—Sorafenib—liver cancer	0.000556	0.00549	CcSEcCtD
Quinine—Flushing—Sorafenib—liver cancer	0.000554	0.00547	CcSEcCtD
Quinine—Cardiac disorder—Sorafenib—liver cancer	0.000554	0.00547	CcSEcCtD
Quinine—Immune system disorder—Sorafenib—liver cancer	0.000539	0.00532	CcSEcCtD
Quinine—Mediastinal disorder—Sorafenib—liver cancer	0.000538	0.00531	CcSEcCtD
Quinine—Scotoma—Doxorubicin—liver cancer	0.000535	0.00528	CcSEcCtD
Quinine—Petechiae—Epirubicin—liver cancer	0.000534	0.00527	CcSEcCtD
Quinine—Mental disorder—Sorafenib—liver cancer	0.000523	0.00516	CcSEcCtD
Quinine—Malnutrition—Sorafenib—liver cancer	0.00052	0.00513	CcSEcCtD
Quinine—Erythema—Sorafenib—liver cancer	0.00052	0.00513	CcSEcCtD
Quinine—Necrosis—Doxorubicin—liver cancer	0.000518	0.00511	CcSEcCtD
Quinine—Vasodilation procedure—Epirubicin—liver cancer	0.0005	0.00493	CcSEcCtD
Quinine—Vasodilation—Epirubicin—liver cancer	0.0005	0.00493	CcSEcCtD
Quinine—Petechiae—Doxorubicin—liver cancer	0.000494	0.00488	CcSEcCtD
Quinine—Bone disorder—Epirubicin—liver cancer	0.000486	0.0048	CcSEcCtD
Quinine—Ventricular extrasystoles—Epirubicin—liver cancer	0.000486	0.0048	CcSEcCtD
Quinine—Oliguria—Epirubicin—liver cancer	0.000477	0.0047	CcSEcCtD
Quinine—Angioedema—Sorafenib—liver cancer	0.000475	0.00469	CcSEcCtD
Quinine—Syncope—Sorafenib—liver cancer	0.000466	0.0046	CcSEcCtD
Quinine—Leukopenia—Sorafenib—liver cancer	0.000465	0.00459	CcSEcCtD
Quinine—Vasodilation procedure—Doxorubicin—liver cancer	0.000463	0.00457	CcSEcCtD
Quinine—Vasodilation—Doxorubicin—liver cancer	0.000463	0.00457	CcSEcCtD
Quinine—Loss of consciousness—Sorafenib—liver cancer	0.000457	0.00451	CcSEcCtD
Quinine—Atrioventricular block—Epirubicin—liver cancer	0.000453	0.00447	CcSEcCtD
Quinine—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00045	0.00444	CcSEcCtD
Quinine—Bone disorder—Doxorubicin—liver cancer	0.00045	0.00444	CcSEcCtD
Quinine—Myalgia—Sorafenib—liver cancer	0.000442	0.00437	CcSEcCtD
Quinine—Oliguria—Doxorubicin—liver cancer	0.000441	0.00435	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000439	0.00434	CcSEcCtD
Quinine—Ventricular tachycardia—Epirubicin—liver cancer	0.000439	0.00434	CcSEcCtD
Quinine—Dermatitis contact—Epirubicin—liver cancer	0.000434	0.00428	CcSEcCtD
Quinine—Atrioventricular block—Doxorubicin—liver cancer	0.000419	0.00414	CcSEcCtD
Quinine—Shock—Sorafenib—liver cancer	0.000417	0.00412	CcSEcCtD
Quinine—Nervous system disorder—Sorafenib—liver cancer	0.000416	0.0041	CcSEcCtD
Quinine—Thrombocytopenia—Sorafenib—liver cancer	0.000415	0.0041	CcSEcCtD
Quinine—Aplastic anaemia—Epirubicin—liver cancer	0.000412	0.00407	CcSEcCtD
Quinine—Skin disorder—Sorafenib—liver cancer	0.000412	0.00407	CcSEcCtD
Quinine—Ventricular tachycardia—Doxorubicin—liver cancer	0.000406	0.00401	CcSEcCtD
Quinine—Anorexia—Sorafenib—liver cancer	0.000404	0.00399	CcSEcCtD
Quinine—Dermatitis contact—Doxorubicin—liver cancer	0.000402	0.00396	CcSEcCtD
Quinine—Oesophagitis—Epirubicin—liver cancer	0.000401	0.00396	CcSEcCtD
Quinine—Coma—Epirubicin—liver cancer	0.000401	0.00396	CcSEcCtD
Quinine—Ecchymosis—Epirubicin—liver cancer	0.000397	0.00392	CcSEcCtD
Quinine—Pulmonary oedema—Epirubicin—liver cancer	0.000391	0.00386	CcSEcCtD
Quinine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000386	0.00381	CcSEcCtD
Quinine—Aplastic anaemia—Doxorubicin—liver cancer	0.000382	0.00377	CcSEcCtD
Quinine—Dyspnoea—Sorafenib—liver cancer	0.000378	0.00373	CcSEcCtD
Quinine—Oesophagitis—Doxorubicin—liver cancer	0.000371	0.00367	CcSEcCtD
Quinine—Coma—Doxorubicin—liver cancer	0.000371	0.00367	CcSEcCtD
Quinine—Decreased appetite—Sorafenib—liver cancer	0.000369	0.00364	CcSEcCtD
Quinine—Ecchymosis—Doxorubicin—liver cancer	0.000367	0.00363	CcSEcCtD
Quinine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000366	0.00361	CcSEcCtD
Quinine—Photosensitivity—Epirubicin—liver cancer	0.000363	0.00358	CcSEcCtD
Quinine—Pulmonary oedema—Doxorubicin—liver cancer	0.000362	0.00357	CcSEcCtD
Quinine—Eczema—Epirubicin—liver cancer	0.000355	0.0035	CcSEcCtD
Quinine—Gastrointestinal pain—Sorafenib—liver cancer	0.000347	0.00342	CcSEcCtD
Quinine—Renal failure acute—Epirubicin—liver cancer	0.000345	0.00341	CcSEcCtD
Quinine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000338	0.00333	CcSEcCtD
Quinine—Urticaria—Sorafenib—liver cancer	0.000337	0.00332	CcSEcCtD
Quinine—Photosensitivity—Doxorubicin—liver cancer	0.000336	0.00332	CcSEcCtD
Quinine—Body temperature increased—Sorafenib—liver cancer	0.000335	0.00331	CcSEcCtD
Quinine—Abdominal pain—Sorafenib—liver cancer	0.000335	0.00331	CcSEcCtD
Quinine—Renal impairment—Epirubicin—liver cancer	0.000335	0.00331	CcSEcCtD
Quinine—Dermatitis bullous—Epirubicin—liver cancer	0.000334	0.00329	CcSEcCtD
Quinine—Purpura—Epirubicin—liver cancer	0.000331	0.00326	CcSEcCtD
Quinine—Eczema—Doxorubicin—liver cancer	0.000328	0.00324	CcSEcCtD
Quinine—Hypoglycaemia—Epirubicin—liver cancer	0.000327	0.00322	CcSEcCtD
Quinine—Renal failure acute—Doxorubicin—liver cancer	0.00032	0.00315	CcSEcCtD
Quinine—Diplopia—Epirubicin—liver cancer	0.000319	0.00315	CcSEcCtD
Quinine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000313	0.00309	CcSEcCtD
Quinine—Hypersensitivity—Sorafenib—liver cancer	0.000312	0.00308	CcSEcCtD
Quinine—Renal impairment—Doxorubicin—liver cancer	0.00031	0.00306	CcSEcCtD
Quinine—Dermatitis bullous—Doxorubicin—liver cancer	0.000309	0.00305	CcSEcCtD
Quinine—Purpura—Doxorubicin—liver cancer	0.000306	0.00302	CcSEcCtD
Quinine—Asthenia—Sorafenib—liver cancer	0.000304	0.003	CcSEcCtD
Quinine—Cardiac arrest—Epirubicin—liver cancer	0.000303	0.00299	CcSEcCtD
Quinine—Hypoglycaemia—Doxorubicin—liver cancer	0.000302	0.00298	CcSEcCtD
Quinine—Pruritus—Sorafenib—liver cancer	0.0003	0.00296	CcSEcCtD
Quinine—Ataxia—Epirubicin—liver cancer	0.0003	0.00296	CcSEcCtD
Quinine—Diplopia—Doxorubicin—liver cancer	0.000295	0.00291	CcSEcCtD
Quinine—Liver function test abnormal—Epirubicin—liver cancer	0.000294	0.00291	CcSEcCtD
Quinine—Orthostatic hypotension—Epirubicin—liver cancer	0.000291	0.00287	CcSEcCtD
Quinine—Abdominal pain upper—Epirubicin—liver cancer	0.000291	0.00287	CcSEcCtD
Quinine—Diarrhoea—Sorafenib—liver cancer	0.00029	0.00286	CcSEcCtD
Quinine—Breast disorder—Epirubicin—liver cancer	0.000288	0.00284	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000287	0.00283	CcSEcCtD
Quinine—Muscular weakness—Epirubicin—liver cancer	0.000281	0.00278	CcSEcCtD
Quinine—Cardiac arrest—Doxorubicin—liver cancer	0.000281	0.00277	CcSEcCtD
Quinine—Dizziness—Sorafenib—liver cancer	0.00028	0.00277	CcSEcCtD
Quinine—Ataxia—Doxorubicin—liver cancer	0.000277	0.00274	CcSEcCtD
Quinine—Asthma—Epirubicin—liver cancer	0.000276	0.00272	CcSEcCtD
Quinine—Liver function test abnormal—Doxorubicin—liver cancer	0.000272	0.00269	CcSEcCtD
Quinine—Vomiting—Sorafenib—liver cancer	0.00027	0.00266	CcSEcCtD
Quinine—Abdominal pain upper—Doxorubicin—liver cancer	0.000269	0.00266	CcSEcCtD
Quinine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000269	0.00266	CcSEcCtD
Quinine—Angina pectoris—Epirubicin—liver cancer	0.000268	0.00265	CcSEcCtD
Quinine—Rash—Sorafenib—liver cancer	0.000267	0.00264	CcSEcCtD
Quinine—Dermatitis—Sorafenib—liver cancer	0.000267	0.00264	CcSEcCtD
Quinine—Breast disorder—Doxorubicin—liver cancer	0.000267	0.00263	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000266	0.00262	CcSEcCtD
Quinine—Headache—Sorafenib—liver cancer	0.000266	0.00262	CcSEcCtD
Quinine—Pancytopenia—Epirubicin—liver cancer	0.000262	0.00258	CcSEcCtD
Quinine—Muscular weakness—Doxorubicin—liver cancer	0.00026	0.00257	CcSEcCtD
Quinine—Neutropenia—Epirubicin—liver cancer	0.000258	0.00254	CcSEcCtD
Quinine—Asthma—Doxorubicin—liver cancer	0.000255	0.00252	CcSEcCtD
Quinine—Nausea—Sorafenib—liver cancer	0.000252	0.00249	CcSEcCtD
Quinine—Photosensitivity reaction—Epirubicin—liver cancer	0.000252	0.00248	CcSEcCtD
Quinine—Angina pectoris—Doxorubicin—liver cancer	0.000248	0.00245	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000244	0.0024	CcSEcCtD
Quinine—Pancytopenia—Doxorubicin—liver cancer	0.000242	0.00239	CcSEcCtD
Quinine—Renal failure—Epirubicin—liver cancer	0.000242	0.00238	CcSEcCtD
Quinine—Jaundice—Epirubicin—liver cancer	0.00024	0.00236	CcSEcCtD
Quinine—Neutropenia—Doxorubicin—liver cancer	0.000238	0.00235	CcSEcCtD
Quinine—Sweating—Epirubicin—liver cancer	0.000236	0.00232	CcSEcCtD
Quinine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000233	0.0023	CcSEcCtD
Quinine—Agranulocytosis—Epirubicin—liver cancer	0.000229	0.00226	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000225	0.00222	CcSEcCtD
Quinine—Bradycardia—Epirubicin—liver cancer	0.000225	0.00222	CcSEcCtD
Quinine—Renal failure—Doxorubicin—liver cancer	0.000223	0.00221	CcSEcCtD
Quinine—Haemoglobin—Epirubicin—liver cancer	0.000222	0.00219	CcSEcCtD
Quinine—Jaundice—Doxorubicin—liver cancer	0.000222	0.00219	CcSEcCtD
Quinine—Hepatitis—Epirubicin—liver cancer	0.000221	0.00218	CcSEcCtD
Quinine—Haemorrhage—Epirubicin—liver cancer	0.000221	0.00218	CcSEcCtD
Quinine—Sweating—Doxorubicin—liver cancer	0.000218	0.00215	CcSEcCtD
Quinine—Urinary tract disorder—Epirubicin—liver cancer	0.000218	0.00215	CcSEcCtD
Quinine—Urethral disorder—Epirubicin—liver cancer	0.000216	0.00213	CcSEcCtD
Quinine—Visual impairment—Epirubicin—liver cancer	0.000213	0.0021	CcSEcCtD
Quinine—Agranulocytosis—Doxorubicin—liver cancer	0.000212	0.00209	CcSEcCtD
Quinine—Erythema multiforme—Epirubicin—liver cancer	0.000209	0.00206	CcSEcCtD
Quinine—Bradycardia—Doxorubicin—liver cancer	0.000208	0.00205	CcSEcCtD
Quinine—Eye disorder—Epirubicin—liver cancer	0.000206	0.00203	CcSEcCtD
Quinine—Tinnitus—Epirubicin—liver cancer	0.000206	0.00203	CcSEcCtD
Quinine—Haemoglobin—Doxorubicin—liver cancer	0.000205	0.00202	CcSEcCtD
Quinine—Flushing—Epirubicin—liver cancer	0.000205	0.00202	CcSEcCtD
Quinine—Cardiac disorder—Epirubicin—liver cancer	0.000205	0.00202	CcSEcCtD
Quinine—Haemorrhage—Doxorubicin—liver cancer	0.000204	0.00201	CcSEcCtD
Quinine—Hepatitis—Doxorubicin—liver cancer	0.000204	0.00201	CcSEcCtD
Quinine—Urinary tract disorder—Doxorubicin—liver cancer	0.000202	0.00199	CcSEcCtD
Quinine—Urethral disorder—Doxorubicin—liver cancer	0.0002	0.00197	CcSEcCtD
Quinine—Immune system disorder—Epirubicin—liver cancer	0.000199	0.00197	CcSEcCtD
Quinine—Mediastinal disorder—Epirubicin—liver cancer	0.000199	0.00196	CcSEcCtD
Quinine—Chills—Epirubicin—liver cancer	0.000198	0.00195	CcSEcCtD
Quinine—Visual impairment—Doxorubicin—liver cancer	0.000197	0.00194	CcSEcCtD
Quinine—Mental disorder—Epirubicin—liver cancer	0.000193	0.00191	CcSEcCtD
Quinine—Erythema multiforme—Doxorubicin—liver cancer	0.000193	0.0019	CcSEcCtD
Quinine—Erythema—Epirubicin—liver cancer	0.000192	0.0019	CcSEcCtD
Quinine—Malnutrition—Epirubicin—liver cancer	0.000192	0.0019	CcSEcCtD
Quinine—Eye disorder—Doxorubicin—liver cancer	0.000191	0.00188	CcSEcCtD
Quinine—Tinnitus—Doxorubicin—liver cancer	0.00019	0.00188	CcSEcCtD
Quinine—Cardiac disorder—Doxorubicin—liver cancer	0.000189	0.00187	CcSEcCtD
Quinine—Flushing—Doxorubicin—liver cancer	0.000189	0.00187	CcSEcCtD
Quinine—Immune system disorder—Doxorubicin—liver cancer	0.000184	0.00182	CcSEcCtD
Quinine—Mediastinal disorder—Doxorubicin—liver cancer	0.000184	0.00182	CcSEcCtD
Quinine—Chills—Doxorubicin—liver cancer	0.000183	0.00181	CcSEcCtD
Quinine—Vision blurred—Epirubicin—liver cancer	0.000181	0.00179	CcSEcCtD
Quinine—Mental disorder—Doxorubicin—liver cancer	0.000179	0.00176	CcSEcCtD
Quinine—Malnutrition—Doxorubicin—liver cancer	0.000178	0.00175	CcSEcCtD
Quinine—Erythema—Doxorubicin—liver cancer	0.000178	0.00175	CcSEcCtD
Quinine—Agitation—Epirubicin—liver cancer	0.000176	0.00174	CcSEcCtD
Quinine—Vertigo—Epirubicin—liver cancer	0.000173	0.0017	CcSEcCtD
Quinine—Syncope—Epirubicin—liver cancer	0.000172	0.0017	CcSEcCtD
Quinine—Leukopenia—Epirubicin—liver cancer	0.000172	0.0017	CcSEcCtD
Quinine—Palpitations—Epirubicin—liver cancer	0.00017	0.00167	CcSEcCtD
Quinine—Loss of consciousness—Epirubicin—liver cancer	0.000169	0.00167	CcSEcCtD
Quinine—Vision blurred—Doxorubicin—liver cancer	0.000167	0.00165	CcSEcCtD
Quinine—Convulsion—Epirubicin—liver cancer	0.000166	0.00164	CcSEcCtD
Quinine—Chest pain—Epirubicin—liver cancer	0.000163	0.00161	CcSEcCtD
Quinine—Myalgia—Epirubicin—liver cancer	0.000163	0.00161	CcSEcCtD
Quinine—Agitation—Doxorubicin—liver cancer	0.000163	0.00161	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000162	0.0016	CcSEcCtD
Quinine—Vertigo—Doxorubicin—liver cancer	0.00016	0.00158	CcSEcCtD
Quinine—Syncope—Doxorubicin—liver cancer	0.000159	0.00157	CcSEcCtD
Quinine—Leukopenia—Doxorubicin—liver cancer	0.000159	0.00157	CcSEcCtD
Quinine—Confusional state—Epirubicin—liver cancer	0.000158	0.00156	CcSEcCtD
Quinine—Palpitations—Doxorubicin—liver cancer	0.000157	0.00155	CcSEcCtD
Quinine—Oedema—Epirubicin—liver cancer	0.000157	0.00155	CcSEcCtD
Quinine—Loss of consciousness—Doxorubicin—liver cancer	0.000156	0.00154	CcSEcCtD
Quinine—Shock—Epirubicin—liver cancer	0.000154	0.00152	CcSEcCtD
Quinine—Convulsion—Doxorubicin—liver cancer	0.000154	0.00152	CcSEcCtD
Quinine—Nervous system disorder—Epirubicin—liver cancer	0.000154	0.00152	CcSEcCtD
Quinine—Thrombocytopenia—Epirubicin—liver cancer	0.000153	0.00151	CcSEcCtD
Quinine—Tachycardia—Epirubicin—liver cancer	0.000153	0.00151	CcSEcCtD
Quinine—Skin disorder—Epirubicin—liver cancer	0.000152	0.0015	CcSEcCtD
Quinine—Hyperhidrosis—Epirubicin—liver cancer	0.000151	0.0015	CcSEcCtD
Quinine—Myalgia—Doxorubicin—liver cancer	0.000151	0.00149	CcSEcCtD
Quinine—Chest pain—Doxorubicin—liver cancer	0.000151	0.00149	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00015	0.00148	CcSEcCtD
Quinine—Anorexia—Epirubicin—liver cancer	0.000149	0.00147	CcSEcCtD
Quinine—Hypotension—Epirubicin—liver cancer	0.000146	0.00145	CcSEcCtD
Quinine—Confusional state—Doxorubicin—liver cancer	0.000146	0.00144	CcSEcCtD
Quinine—Oedema—Doxorubicin—liver cancer	0.000145	0.00143	CcSEcCtD
Quinine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000143	0.00141	CcSEcCtD
Quinine—Shock—Doxorubicin—liver cancer	0.000143	0.00141	CcSEcCtD
Quinine—Nervous system disorder—Doxorubicin—liver cancer	0.000142	0.0014	CcSEcCtD
Quinine—Thrombocytopenia—Doxorubicin—liver cancer	0.000142	0.0014	CcSEcCtD
Quinine—Tachycardia—Doxorubicin—liver cancer	0.000142	0.0014	CcSEcCtD
Quinine—Skin disorder—Doxorubicin—liver cancer	0.000141	0.00139	CcSEcCtD
Quinine—Hyperhidrosis—Doxorubicin—liver cancer	0.00014	0.00138	CcSEcCtD
Quinine—Dyspnoea—Epirubicin—liver cancer	0.00014	0.00138	CcSEcCtD
Quinine—Anorexia—Doxorubicin—liver cancer	0.000138	0.00136	CcSEcCtD
Quinine—Decreased appetite—Epirubicin—liver cancer	0.000136	0.00134	CcSEcCtD
Quinine—Hypotension—Doxorubicin—liver cancer	0.000135	0.00134	CcSEcCtD
Quinine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000135	0.00134	CcSEcCtD
Quinine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000132	0.0013	CcSEcCtD
Quinine—Dyspnoea—Doxorubicin—liver cancer	0.000129	0.00128	CcSEcCtD
Quinine—Feeling abnormal—Epirubicin—liver cancer	0.000129	0.00127	CcSEcCtD
Quinine—Gastrointestinal pain—Epirubicin—liver cancer	0.000128	0.00126	CcSEcCtD
Quinine—Decreased appetite—Doxorubicin—liver cancer	0.000126	0.00124	CcSEcCtD
Quinine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000125	0.00124	CcSEcCtD
Quinine—Urticaria—Epirubicin—liver cancer	0.000124	0.00123	CcSEcCtD
Quinine—Abdominal pain—Epirubicin—liver cancer	0.000124	0.00122	CcSEcCtD
Quinine—Body temperature increased—Epirubicin—liver cancer	0.000124	0.00122	CcSEcCtD
Quinine—Feeling abnormal—Doxorubicin—liver cancer	0.000119	0.00118	CcSEcCtD
Quinine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000119	0.00117	CcSEcCtD
Quinine—Hypersensitivity—Epirubicin—liver cancer	0.000115	0.00114	CcSEcCtD
Quinine—Urticaria—Doxorubicin—liver cancer	0.000115	0.00114	CcSEcCtD
Quinine—Body temperature increased—Doxorubicin—liver cancer	0.000115	0.00113	CcSEcCtD
Quinine—Abdominal pain—Doxorubicin—liver cancer	0.000115	0.00113	CcSEcCtD
Quinine—Asthenia—Epirubicin—liver cancer	0.000112	0.00111	CcSEcCtD
Quinine—Pruritus—Epirubicin—liver cancer	0.000111	0.00109	CcSEcCtD
Quinine—Diarrhoea—Epirubicin—liver cancer	0.000107	0.00106	CcSEcCtD
Quinine—Hypersensitivity—Doxorubicin—liver cancer	0.000107	0.00105	CcSEcCtD
Quinine—Asthenia—Doxorubicin—liver cancer	0.000104	0.00103	CcSEcCtD
Quinine—Dizziness—Epirubicin—liver cancer	0.000104	0.00102	CcSEcCtD
Quinine—Pruritus—Doxorubicin—liver cancer	0.000103	0.00101	CcSEcCtD
Quinine—Vomiting—Epirubicin—liver cancer	9.96e-05	0.000983	CcSEcCtD
Quinine—Diarrhoea—Doxorubicin—liver cancer	9.92e-05	0.000979	CcSEcCtD
Quinine—Rash—Epirubicin—liver cancer	9.88e-05	0.000975	CcSEcCtD
Quinine—Dermatitis—Epirubicin—liver cancer	9.87e-05	0.000974	CcSEcCtD
Quinine—Headache—Epirubicin—liver cancer	9.82e-05	0.000969	CcSEcCtD
Quinine—Dizziness—Doxorubicin—liver cancer	9.59e-05	0.000946	CcSEcCtD
Quinine—Nausea—Epirubicin—liver cancer	9.31e-05	0.000919	CcSEcCtD
Quinine—Vomiting—Doxorubicin—liver cancer	9.22e-05	0.00091	CcSEcCtD
Quinine—Rash—Doxorubicin—liver cancer	9.14e-05	0.000902	CcSEcCtD
Quinine—Dermatitis—Doxorubicin—liver cancer	9.13e-05	0.000901	CcSEcCtD
Quinine—Headache—Doxorubicin—liver cancer	9.08e-05	0.000897	CcSEcCtD
Quinine—Nausea—Doxorubicin—liver cancer	8.61e-05	0.00085	CcSEcCtD
Quinine—CYP2D6—Metabolism—PSMA4—liver cancer	7.37e-06	7.13e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PSMD10—liver cancer	7.37e-06	7.13e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CG—liver cancer	7.36e-06	7.13e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CYP2E1—liver cancer	7.32e-06	7.09e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.32e-06	7.09e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PSMA4—liver cancer	7.3e-06	7.07e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PSMD10—liver cancer	7.3e-06	7.07e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—HMOX1—liver cancer	7.28e-06	7.05e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTA4—liver cancer	7.27e-06	7.04e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	7.21e-06	6.98e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PIK3CB—liver cancer	7.2e-06	6.97e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GSTM1—liver cancer	7.19e-06	6.97e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GSTM1—liver cancer	7.18e-06	6.95e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GOT2—liver cancer	7.16e-06	6.94e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CYP2E1—liver cancer	7.15e-06	6.92e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PPARG—liver cancer	7.12e-06	6.89e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PPARG—liver cancer	7.11e-06	6.88e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GOT2—liver cancer	7.1e-06	6.88e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.09e-06	6.87e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTA2—liver cancer	7.08e-06	6.86e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—HPGDS—liver cancer	7e-06	6.78e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CSF2—liver cancer	6.99e-06	6.77e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—RAF1—liver cancer	6.97e-06	6.75e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.96e-06	6.74e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—H2AFX—liver cancer	6.89e-06	6.67e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—IL2—liver cancer	6.89e-06	6.67e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CG—liver cancer	6.86e-06	6.65e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CYCS—liver cancer	6.85e-06	6.64e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTA1—liver cancer	6.83e-06	6.62e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CYP1A1—liver cancer	6.82e-06	6.61e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	6.81e-06	6.59e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CYP1A1—liver cancer	6.81e-06	6.59e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GSTM1—liver cancer	6.78e-06	6.57e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTP1—liver cancer	6.77e-06	6.55e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—NAT2—liver cancer	6.76e-06	6.54e-05	CbGpPWpGaD
Quinine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	6.74e-06	6.53e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CYP2E1—liver cancer	6.74e-06	6.52e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GGT1—liver cancer	6.72e-06	6.51e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GOT1—liver cancer	6.72e-06	6.51e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CYCS—liver cancer	6.69e-06	6.48e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CYP2E1—liver cancer	6.68e-06	6.47e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—HMOX1—liver cancer	6.67e-06	6.46e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PPARG—liver cancer	6.62e-06	6.42e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GOT1—liver cancer	6.56e-06	6.36e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GGT1—liver cancer	6.56e-06	6.36e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CD—liver cancer	6.48e-06	6.28e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ALDOB—liver cancer	6.48e-06	6.27e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CD—liver cancer	6.47e-06	6.27e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.47e-06	6.26e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—ALB—liver cancer	6.4e-06	6.2e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—ALB—liver cancer	6.39e-06	6.19e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—MTHFR—liver cancer	6.36e-06	6.16e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—MTHFR—liver cancer	6.34e-06	6.14e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	6.34e-06	6.14e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CYCS—liver cancer	6.3e-06	6.1e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	6.26e-06	6.06e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL2—liver cancer	6.25e-06	6.06e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CYCS—liver cancer	6.25e-06	6.05e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PSMA4—liver cancer	6.24e-06	6.04e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PSMD10—liver cancer	6.24e-06	6.04e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PPARA—liver cancer	6.24e-06	6.04e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TERT—liver cancer	6.23e-06	6.03e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PPARA—liver cancer	6.22e-06	6.03e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTM1—liver cancer	6.22e-06	6.02e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GGT1—liver cancer	6.18e-06	5.99e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GOT1—liver cancer	6.18e-06	5.99e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CRABP1—liver cancer	6.18e-06	5.99e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GGT1—liver cancer	6.13e-06	5.94e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GOT1—liver cancer	6.13e-06	5.94e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GOT2—liver cancer	6.07e-06	5.88e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTP1—liver cancer	6.04e-06	5.85e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CD—liver cancer	6.03e-06	5.84e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—MTHFR—liver cancer	5.99e-06	5.81e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—HMOX1—liver cancer	5.96e-06	5.77e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—ALB—liver cancer	5.96e-06	5.77e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTP1—liver cancer	5.9e-06	5.71e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CYP1A1—liver cancer	5.89e-06	5.71e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PPARA—liver cancer	5.88e-06	5.7e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—HMOX1—liver cancer	5.81e-06	5.63e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CYP2E1—liver cancer	5.71e-06	5.53e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KDR—liver cancer	5.7e-06	5.52e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAPK14—liver cancer	5.66e-06	5.48e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CB—liver cancer	5.65e-06	5.47e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CB—liver cancer	5.64e-06	5.46e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTP1—liver cancer	5.56e-06	5.38e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ESR1—liver cancer	5.55e-06	5.38e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTM1—liver cancer	5.55e-06	5.38e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.53e-06	5.35e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTP1—liver cancer	5.51e-06	5.33e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—MTHFR—liver cancer	5.5e-06	5.32e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—F2—liver cancer	5.49e-06	5.31e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—HMOX1—liver cancer	5.48e-06	5.31e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—HMOX1—liver cancer	5.43e-06	5.26e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTM1—liver cancer	5.42e-06	5.25e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—HPGDS—liver cancer	5.4e-06	5.23e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PPARA—liver cancer	5.39e-06	5.22e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CG—liver cancer	5.34e-06	5.17e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CYCS—liver cancer	5.34e-06	5.17e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CG—liver cancer	5.33e-06	5.16e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.28e-06	5.12e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CYP1A1—liver cancer	5.26e-06	5.1e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CB—liver cancer	5.26e-06	5.09e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—APC—liver cancer	5.25e-06	5.08e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CG—liver cancer	5.25e-06	5.08e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GGT1—liver cancer	5.24e-06	5.07e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GOT1—liver cancer	5.24e-06	5.07e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PPARG—liver cancer	5.16e-06	4.99e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PPARG—liver cancer	5.15e-06	4.98e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CYP1A1—liver cancer	5.14e-06	4.97e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTM1—liver cancer	5.11e-06	4.94e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTM1—liver cancer	5.06e-06	4.9e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CG—liver cancer	5.04e-06	4.88e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—BRAF—liver cancer	4.93e-06	4.78e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—MTHFR—liver cancer	4.91e-06	4.75e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PPARG—liver cancer	4.86e-06	4.71e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.84e-06	4.69e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CYP1A1—liver cancer	4.84e-06	4.69e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PSMA4—liver cancer	4.82e-06	4.66e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PSMD10—liver cancer	4.82e-06	4.66e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PPARA—liver cancer	4.81e-06	4.66e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CYP1A1—liver cancer	4.8e-06	4.65e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—MTHFR—liver cancer	4.79e-06	4.64e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTP1—liver cancer	4.71e-06	4.56e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PPARA—liver cancer	4.7e-06	4.55e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CD—liver cancer	4.7e-06	4.55e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CD—liver cancer	4.69e-06	4.54e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GOT2—liver cancer	4.68e-06	4.54e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—HMOX1—liver cancer	4.64e-06	4.5e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—ALB—liver cancer	4.64e-06	4.49e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—ALB—liver cancer	4.63e-06	4.48e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CG—liver cancer	4.62e-06	4.47e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CD—liver cancer	4.61e-06	4.47e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	4.57e-06	4.43e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—SERPINE1—liver cancer	4.56e-06	4.42e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—KRAS—liver cancer	4.52e-06	4.38e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—MTHFR—liver cancer	4.51e-06	4.37e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—MTHFR—liver cancer	4.47e-06	4.33e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PPARG—liver cancer	4.46e-06	4.32e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CD—liver cancer	4.43e-06	4.29e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PPARA—liver cancer	4.43e-06	4.29e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYP2E1—liver cancer	4.4e-06	4.27e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PIK3CA—liver cancer	4.39e-06	4.25e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PPARA—liver cancer	4.39e-06	4.25e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—ALB—liver cancer	4.37e-06	4.23e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTM1—liver cancer	4.32e-06	4.19e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.32e-06	4.19e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	4.15e-06	4.02e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CG—liver cancer	4.12e-06	3.99e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYCS—liver cancer	4.12e-06	3.99e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—RAF1—liver cancer	4.12e-06	3.99e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CYP1A1—liver cancer	4.1e-06	3.97e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CB—liver cancer	4.09e-06	3.96e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CB—liver cancer	4.08e-06	3.96e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CD—liver cancer	4.06e-06	3.93e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GGT1—liver cancer	4.04e-06	3.92e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GOT1—liver cancer	4.04e-06	3.92e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CG—liver cancer	4.02e-06	3.9e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MTOR—liver cancer	4.02e-06	3.9e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CB—liver cancer	4.02e-06	3.9e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ALB—liver cancer	4.01e-06	3.88e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PPARG—liver cancer	3.98e-06	3.85e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.94e-06	3.82e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PPARG—liver cancer	3.88e-06	3.76e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CB—liver cancer	3.86e-06	3.74e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—HRAS—liver cancer	3.84e-06	3.72e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—MTHFR—liver cancer	3.82e-06	3.7e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CG—liver cancer	3.79e-06	3.67e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CDKN1B—liver cancer	3.77e-06	3.66e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CG—liver cancer	3.76e-06	3.64e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PPARA—liver cancer	3.75e-06	3.63e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—AKT1—liver cancer	3.73e-06	3.62e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CASP3—liver cancer	3.7e-06	3.58e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL2—liver cancer	3.69e-06	3.58e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL6—liver cancer	3.68e-06	3.56e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PPARG—liver cancer	3.66e-06	3.54e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTP1—liver cancer	3.63e-06	3.52e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PPARG—liver cancer	3.63e-06	3.51e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CD—liver cancer	3.62e-06	3.51e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CCND1—liver cancer	3.6e-06	3.49e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—JUN—liver cancer	3.59e-06	3.48e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—AKT1—liver cancer	3.59e-06	3.47e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—HMOX1—liver cancer	3.58e-06	3.47e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ALB—liver cancer	3.58e-06	3.46e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CTNNB1—liver cancer	3.57e-06	3.45e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CB—liver cancer	3.54e-06	3.43e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CD—liver cancer	3.54e-06	3.42e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MMP9—liver cancer	3.5e-06	3.39e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—ALB—liver cancer	3.49e-06	3.38e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CDKN1A—liver cancer	3.48e-06	3.37e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CA—liver cancer	3.44e-06	3.34e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CA—liver cancer	3.44e-06	3.33e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAPK8—liver cancer	3.4e-06	3.29e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—AKT1—liver cancer	3.39e-06	3.28e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.37e-06	3.26e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTM1—liver cancer	3.34e-06	3.23e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CD—liver cancer	3.33e-06	3.23e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CD—liver cancer	3.3e-06	3.2e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ALB—liver cancer	3.29e-06	3.19e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ALB—liver cancer	3.26e-06	3.16e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CG—liver cancer	3.21e-06	3.11e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CA—liver cancer	3.21e-06	3.1e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYP1A1—liver cancer	3.16e-06	3.06e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CB—liver cancer	3.16e-06	3.06e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—VEGFA—liver cancer	3.14e-06	3.04e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—STAT3—liver cancer	3.11e-06	3.01e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PPARG—liver cancer	3.1e-06	3e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CB—liver cancer	3.08e-06	2.99e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—MTHFR—liver cancer	2.95e-06	2.86e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CB—liver cancer	2.9e-06	2.81e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PPARA—liver cancer	2.89e-06	2.8e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MYC—liver cancer	2.89e-06	2.8e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TGFB1—liver cancer	2.88e-06	2.79e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CB—liver cancer	2.88e-06	2.79e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CD—liver cancer	2.82e-06	2.73e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—AKT1—liver cancer	2.81e-06	2.73e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—AKT1—liver cancer	2.81e-06	2.72e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ALB—liver cancer	2.79e-06	2.7e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KRAS—liver cancer	2.67e-06	2.58e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—AKT1—liver cancer	2.62e-06	2.54e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CA—liver cancer	2.5e-06	2.42e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CA—liver cancer	2.49e-06	2.41e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CG—liver cancer	2.48e-06	2.4e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CB—liver cancer	2.46e-06	2.38e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CA—liver cancer	2.45e-06	2.37e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PPARG—liver cancer	2.39e-06	2.32e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TP53—liver cancer	2.37e-06	2.3e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CA—liver cancer	2.35e-06	2.28e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—HRAS—liver cancer	2.27e-06	2.2e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CD—liver cancer	2.18e-06	2.11e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL6—liver cancer	2.17e-06	2.1e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CA—liver cancer	2.16e-06	2.09e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ALB—liver cancer	2.15e-06	2.08e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—AKT1—liver cancer	2.04e-06	1.97e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—AKT1—liver cancer	2.03e-06	1.97e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—AKT1—liver cancer	2e-06	1.94e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CA—liver cancer	1.93e-06	1.86e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—AKT1—liver cancer	1.92e-06	1.86e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.9e-06	1.84e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CA—liver cancer	1.88e-06	1.82e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.77e-06	1.71e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—AKT1—liver cancer	1.76e-06	1.71e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CA—liver cancer	1.76e-06	1.7e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—AKT1—liver cancer	1.57e-06	1.52e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—AKT1—liver cancer	1.53e-06	1.49e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CA—liver cancer	1.5e-06	1.45e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—AKT1—liver cancer	1.45e-06	1.4e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—AKT1—liver cancer	1.43e-06	1.39e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—AKT1—liver cancer	1.23e-06	1.19e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.16e-06	1.12e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—AKT1—liver cancer	9.46e-07	9.16e-06	CbGpPWpGaD
